GIA
MRNA icon

GHP Investment Advisors’s Moderna MRNA Stock Holding History

GHP Investment Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.78K Hold
54
– – ﹤0.01% 932
2026
Q1 		$2.74K Buy
54
+14
+35% +$653 ﹤0.01% 972
2025
Q4 		$1.18K Hold
40
– – ﹤0.01% 909
2025
Q3 		$1.03K Sell
40
-179
-82% -$4.99K ﹤0.01% 883
2025
Q2 		$6.04K Buy
219
+179
+448% +$4.71K ﹤0.01% 760
2025
Q1 		$1.13K Hold
40
– – ﹤0.01% 876
2024
Q4 		$1.66K Hold
40
– – ﹤0.01% 897
2024
Q3 		$2.67K Hold
40
– – ﹤0.01% 871
2024
Q2 		$4.75K Sell
40
-200
-83% -$25.3K ﹤0.01% 781
2024
Q1 		$25.6K Buy
240
+20
+9% +$2.02K ﹤0.01% 555
2023
Q4 		$21.9K Sell
220
-40
-15% -$3.36K ﹤0.01% 561
2023
Q3 		$25.6K Hold
260
– – ﹤0.01% 577
2023
Q2 		$26.4K Buy
260
+75
+41% +$10K ﹤0.01% 563
2023
Q1 		$28.4K Buy
185
+125
+208% +$20.6K ﹤0.01% 553
2022
Q4 		$10.8K Hold
60
– – ﹤0.01% 677
2022
Q3 		$7K Sell
60
-86
-59% -$13K ﹤0.01% 746
2022
Q2 		$21K Buy
146
+15
+11% +$2.14K ﹤0.01% 573
2022
Q1 		$23K Buy
+131
New +$22.1K ﹤0.01% 589

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

GHP Investment Advisors's MRNA Position: Q2 2026 in Review

GHP Investment Advisors held its Moderna (MRNA) position steady in Q2 2026 at 54 shares worth $3.78K. The position accounts for ﹤0.01% of the portfolio, ranked #932.

GHP Investment Advisors first reported a position in MRNA in Q1 2022 and has held it in 18 quarters since. The position peaked at $28.4K in Q1 2023. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • GHP Investment Advisors held 54 shares of Moderna worth $3.78K as of Q2 2026.
  • GHP Investment Advisors left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #932 holding.
  • GHP Investment Advisors first reported a position in Moderna in Q1 2022 and has held it in 18 quarters since.
  • GHP Investment Advisors's Moderna position peaked at $28.4K in Q1 2023.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.